Group 1 - The company announced the removal of Dr. Xie Weiyi from the board due to unresolved legal disputes and bankruptcy petitions against him, as well as formal notifications from the Hong Kong government regarding his unpaid debts [1] - The board sought legal advice from Cayman Islands counsel regarding the interpretation of Article 86(4) of the company's articles of association, which pertains to the disqualification of directors who suspend debt repayment or reach settlement agreements with creditors [1] - A board meeting was held on August 1, 2025, where a majority decision was made to revoke Dr. Xie Weiyi's directorship, effective immediately, with two directors opposing the decision due to conflicts of interest [1] Group 2 - Mr. Wang Can, an independent non-executive director, appointed Mr. Jiang Bo, an executive director, as his alternate to vote on resolutions during the board meeting, without extending this appointment to other roles [2]
清晰医疗：撤销谢伟业的董事职位